INSYNC SENTRY CRT-D/CONCERTO ICD/CONSULTA CRT-D/CONCERTO II CRT-D/MAXIMO II CRT-D/PROTECTA/XT CRT-D
FDA premarket approval P010031/S253 · decided 2011-05-26
Approval details
- PMA number
- P010031
- Supplement
- S253
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- INSYNC SENTRY CRT-D/CONCERTO ICD/CONSULTA CRT-D/CONCERTO II CRT-D/MAXIMO II CRT-D/PROTECTA/XT CRT-D
- Applicant
- Medtronic Cardiac Rhythm Disease Management
- Date received
- 2011-04-29
- Decision date
- 2011-05-26
- Days to decision
- 27 days
- Decision code
- OK30
- Advisory committee
- Cardiovascular
- Expedited review
- No
- Location
- Mounds View, MN
- Statement
- UPDATE TO PROCESS OPERATION DESCRIPTIONS AND THE IMPLEMENTATION OF NEW TEST MONITORING FOR PACKAGING.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.